🔎 Trials Near Me

Home › Bronchiolitis Obliterans Syndrome › Illinois

Pag-aaral pangklinika para sa Bronchiolitis Obliterans Syndrome sa Illinois

6 pag-aaral para sa Bronchiolitis Obliterans Syndrome ang naghahanap ng mga kalahok sa mga site sa Illinois.

Mga Lungsod sa Illinois

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

  • Northwestern Memorial Hospital, Chicago
  • University of Illinois, Chicago
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06585774

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

  • Northwestern University, Chicago
  • Rush University Medical Group, Chicago
  • The University of Chicago, Chicago
  • at 1 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05919511

Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT06663722

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

  • The University of Chicago Medical Center (UCMC), Chicago
Nagre-recruitPhase 2
Edad 2 pataas · Lahat ng kasarian · Na-update Hun 16, 2026 · NCT04710576

Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)

  • Endeavor Health, Evanston
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT06464926

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • University of Illinois Medical Center - Hematology & Oncology, Chicago
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 15, 2025 · NCT06619561

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.